Why Real-World Data is Key to Helping Advance Cataract Surgery Outcomes
Author:
Durga Borkar, MD, MMCi
Verana Health Medical Advisor
Cataracts remain a leading cause of reversible vision impairment, affecting millions of individuals as they age. Cataract surgery, a widely performed and highly successful procedure, has transformed lives by restoring sight. Yet, despite its ubiquity and efficacy, critical questions remain about long-term outcomes, intraocular lens (IOL) selection, and surgical technique optimization, particularly as more IOLs and surgical tools are available to surgeons.
Verana Health is harnessing the power of real-world data (RWD) and secure, advanced artificial intelligence (AI) to fill these knowledge gaps. This year, the digital health company launched a comprehensive research-ready dataset to support clinical research, enhance treatment pathways, and improve patient care.
Unlocking Real-World Insights in Cataract Surgery
Qdata® Cataracts leverages exclusive, de-identified electronic health record (EHR) data from the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) to offer a granular view of cataract surgery outcomes. With data on more than 9 million patients and an average follow-up of nearly four years, this dataset provides clinicians and life sciences companies with a powerful tool to analyze treatment effectiveness, surgical advancements, and patient experiences.
Traditionally, researchers have relied on clinical trials or claims data to assess cataract surgery outcomes. However, these sources often lack the depth and breadth necessary to fully understand patient journeys. Insights from Qdata Cataracts can help bridge this gap by extracting key clinical variables from both structured and unstructured EHR data, using artificial intelligence techniques, such as machine learning and natural language processing.
Critical insights available include:
- Visual acuity (VA): A fundamental measure of post-surgical success
- Intraocular pressure (IOP) readings: Key to understanding ocular health post-surgery
- Intraocular lens (IOL) brand and model: Informing best practices for lens selection
- Femtosecond laser-assisted cataract surgery (FLACS): A minimally invasive alternative to traditional cataract surgery
Transforming Cataract Research and Treatment
The implications of these insights are vast and can help:
- Optimize clinical trial design by identifying ideal patient cohorts and trial sites
- Advance comparative effectiveness research on different surgical techniques and IOL models
- Enhance commercialization strategies through a data-driven understanding of treatment patterns
- Improve health outcomes research (HEOR) by analyzing real-world patient experiences and complications
One of the most promising applications of this dataset is its ability to inform personalized patient care. By analyzing detailed clinical characteristics, treatment histories, and outcomes from millions of cataract surgeries, Qdata Cataracts enables a nuanced understanding of which patients are most likely to benefit from specific surgical techniques or IOL types. For instance, life sciences companies can:
- Directly compare the effectiveness of different IOL designs (e.g., monofocal vs. multifocal vs. EDOF, toric vs. non-toric) in achieving visual acuity in a large, heterogeneous patient pool, helping inform physician choice and refine patient selection criteria.
- Analyze the real-world visual outcomes (e.g., uncorrected and corrected distance, intermediate, and near visual acuity) associated with specific IOL models across a diverse patient population.
- Identify specific patient subgroups (e.g., those with pre-existing ocular comorbidities like glaucoma or macular degeneration) who may benefit more or less from particular IOL designs.
- Track visual acuity and other relevant outcomes (e.g., incidence of posterior capsule opacification, need for secondary procedures) over extended periods, providing valuable insights into the long-term durability and patient satisfaction with different IOLs.
This level of individualized insight empowers more informed, data-backed decisions.
The Future of Ophthalmic Real-World Evidence
With high-quality, regulatory-grade real-world evidence, we can enhance clinical decision-making, drive innovation, and improve patient outcomes. Cataract surgery may already be one of the most successful medical procedures, but with the power of real-world data, we can make it even better.
Let's Accelerate Research Together
To learn more about Verana Health, please fill out the information below and our team will follow up with you as soon as possible.